Yilian Nuclear Medicine
Latest round
- Series A
Last raised
- Nov 2026
Total raised
- $60M
Investors
- —
About Yilian Nuclear Medicine
The company will use the funds to push its innovative radiopharmaceutical pipeline toward clinical development.
Who invested in Yilian Nuclear Medicine
No investors have been named on Yilian Nuclear Medicine's rounds yet.
Funding rounds
Series A
Nov 12, 2026
Amount
$60M
Investors
Questions about Yilian Nuclear Medicine
How much funding has Yilian Nuclear Medicine raised?
Yilian Nuclear Medicine has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Yilian Nuclear Medicine last raise money?
Yilian Nuclear Medicine's most recent round on record is a Series A, in Nov 2026.
What does Yilian Nuclear Medicine do?
The company will use the funds to push its innovative radiopharmaceutical pipeline toward clinical development.
Where is Yilian Nuclear Medicine headquartered?
Yilian Nuclear Medicine is headquartered in China.
Which VCs invest in companies like Yilian Nuclear Medicine?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back health & biotech companies at Yilian Nuclear Medicine's stage. Their profiles are linked below.
VCs backing health & biotech startups at Series A
Raising like Yilian Nuclear Medicine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.